Clinical trials recruiting for Cardiovascular Risk
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Insulin glargine U-100 | 1 |
| Zenagamtide | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| Arizona | 1 |
| California | 1 |
| Florida | 1 |
| Georgia | 1 |
| Idaho | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Iowa | 1 |
| Kansas | 1 |
| Kentucky | 1 |
| Louisiana | 1 |
Top cities
Self-screener
Recruiting trials
- AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Cardiometabolic Risk of Obese Subjects: Cross-sectional Study
- Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk
- The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT
Related conditions
Trials recruiting for Cardiovascular Risk often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cardiovascular Risk trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.